KRAS-G12D inhibitor HRS-4642 plus chemotherapy in advanced KRAS(G12D)-mutant pancreatic cancer: a phase 1b/2 trial. (nature.com)

Authors: Cui J … Wang L Journal: Nature Medicine Published: 2026-07-09 DOI: https://doi.org/10.1038/s41591-026-04538-9